Coherus BioSciences
(NASDAQ:CHRS)
7.50
0.11[1.49%]
At close: Jun 24
7.50
00
After Hours: 4:04PM EDT
15 minutes delayed
Day High/Low7.22 - 7.66
52 Week High/Low5.6 - 19.32
Open / Close7.48 / 7.5
Float / Outstanding61.1M / 77.4M
Vol / Avg.1.8M / 1M
Mkt Cap580.7M
P/E-
50d Avg. Price8.2
Div / Yield-
Payout Ratio-
EPS-1.24
Total Float61.1M

Coherus BioSciences (NASDAQ:CHRS), Quotes and News Summary

Coherus BioSciences (NASDAQ: CHRS)

Day High/Low7.22 - 7.66
52 Week High/Low5.6 - 19.32
Open / Close7.48 / 7.5
Float / Outstanding61.1M / 77.4M
Vol / Avg.1.8M / 1M
Mkt Cap580.7M
P/E-
50d Avg. Price8.2
Div / Yield-
Payout Ratio-
EPS-1.24
Total Float61.1M
load more
Sector: Health Care.Industry: Biotechnology
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an innovative immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. Toripalimab is being evaluated in pivotal clinical trials for the treatment of cancers of the lung, breast, liver, skin, kidney, stomach, esophagus, and bladder. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company is also developing CHS-305, a biosimilar of Avastin. The company generates revenue primarily from the United States.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.480-1.000 -0.5200
REV68.950M60.115M-8.835M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Coherus BioSciences Questions & Answers

Q
How do I buy Coherus BioSciences (CHRS) stock?
A

You can purchase shares of Coherus BioSciences (NASDAQ: CHRS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Coherus BioSciences's (CHRS) competitors?
Q
What is the target price for Coherus BioSciences (CHRS) stock?
A

The latest price target for Coherus BioSciences (NASDAQ: CHRS) was reported by UBS on Tuesday, June 14, 2022. The analyst firm set a price target for 7.00 expecting CHRS to fall to within 12 months (a possible -6.67% downside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Coherus BioSciences (CHRS)?
A

The stock price for Coherus BioSciences (NASDAQ: CHRS) is $7.5 last updated Today at June 24, 2022, 8:00 PM UTC.

Q
Does Coherus BioSciences (CHRS) pay a dividend?
A

There are no upcoming dividends for Coherus BioSciences.

Q
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
A

Coherus BioSciences’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Coherus BioSciences (CHRS) going to split?
A

There is no upcoming split for Coherus BioSciences.

Q
What sector and industry does Coherus BioSciences (CHRS) operate in?
A

Coherus BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.